Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers

Uterine serous carcinoma (USC) and carcinosarcomas (CSs) are rare, highly aggressive variants of endometrial cancer. No reliable tumor biomarkers are currently available to guide response to treatment or detection of early recurrence in USC/CS patients. Circulating tumor DNA (ctDNA) identified using...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellone, Stefania, McNamara, Blair, Mutlu, Levent, Demirkiran, Cem, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Siegel, Eric R., Santin, Alessandro D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219151/
https://www.ncbi.nlm.nih.gov/pubmed/37240216
http://dx.doi.org/10.3390/ijms24108873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219151/
https://www.ncbi.nlm.nih.gov/pubmed/37240216
http://dx.doi.org/10.3390/ijms24108873

Ejemplares similares